Previous Article ] Menu ] Next Article ]


Modern Medical Cancer Therapy Following
the Decline of Toxic Chemotherapy

Editor:

    As Dr. Ralph Moss, the former Research Speaker of the Sloan Kettering Cancer Institute in New York and author of Questioning Chemotherapy, (Equinox Press, NY) has correctly pointed out, cancer chemotherapy is a complex of the age slowly going under, with relatively limited exceptions. Not only that it disappoints millions of cancer victims who have invested hope in chemotherapy, the great failure of toxic cancer chemotherapy (which may also include interferon and interleukin in particular) leads also to a tremendous draining of health care money money which has become very short.

    When a ship is about to go under people are hoping for a rescue vessel. Which procedures in cancer therapy could eventually offer a better alternative?

1) Tumor resection, debulking or destruction by physics means, as early as possible.

2) Immediate preventive, protective, or curative therapy following surgery, for unlimited time. This therapy has to be absolutely nontoxic, the disease should not have a chance to outlive the therapy due to the toxicity of the latter.

    The measures which should be taken into account once the confrontation with a malignant disease has been established, irrespective of a foregoing surgical procedure are the following:

a) Removal of the patient from sites of geopathogenic exposure. Ninety-three percent (93%) of all patients having contracted a malignancy have been exposed to those. We provide patients with the addresses of reliable dowsers or providers of the Meersmann geomagnetometer.

b) Appropriate diet. Restrict meat, no meat of growing animals. Restrict cheese and any food rich in sugar. Prefer fiber-rich food, raw food (fruit, salads) millet, buckwheat. Prefer juice rich in anthocyans (red beets, blueberry) or rich in enzymes (e.g. papaya). Carotene, mainly in the form of juice or powder in capsules (not in an oily base). Do not combine with vitamin A!

c) The basic therapy should include: tripertinoid squalene (2-4 gm.) combined with vitamin C, preferably as calcium ascorbate. These two substances help the organism to develop several defense factors against both malignant cells and herpes type viruses of which several are oncogenic. The effects of squalene plus ascorbate can be measured by an increase of the hormone dehydroepiandroterone (DHEA) and of the enzyme cholinesterase (ChE).

    Squalene, vitamin C and ergocalciferol (vitamin D2) also result in the formation of thymic factors, including the short-lived endiol Tumosterone, a genetic repair anti-malignant and anti-herpes substance. (Klemke)

The deshielding natural enzyme bromelain.

The best of the available thymus preparations, both orally and for intramuscular injection.

The best of the available digestive enzymes, higher doses of pancreatin are very welcomed.

d) Special therapies: Oncostatin, an embryonic genetic repair and redifferentiation factor (Ney-Tumorin) mainly in the case of plasmocytoma and myeloma. Can be combined with chemotherapy (Melphalan).

Zinc-orotate and zinc-aspartate (120 mgs each per day) as inhibitors of thymidine kinase and virus replication in Hodgkin and Non-Hodgkin lymphomas, combined with gamma globulin. LDH and AP have to drop under this therapy, otherwise discontinue. This therapy can well be combined with chemotherapy, e.g. foregoing COP or CHOP programs.

Urea Pura therapy, the Danopoulos program. Mainly in the management of larger tumors or of primary liver malignancies. Intravenous infusion of Sterofundin/Ionosterile Ringer of 6-12 grams of urea per day. Or orally together with K-Mg-aspartate if the urea level in the blood is low which is extremely often in the case of patients who are tumor-prone.

Reduced glutathione activated by l-cysteine and anthocyane has been shown to induce apoptosis, a self-switch-off of cancer cells. The clinical results are evident under certain, but rare, conditions.

Alpha-Interferon has genetic repair (redifferentiation) properties. This, however, in small doses which are accepted by the organism without disequilibrating intolerances. (Robert C. Atkins).

e) The most important genetic repair substances found in nature and phylogenetically the oldest ones and the most powerful ones all have one property in common: They are aldehydes.

1) Acetaldehyde (7.5 gm. in 200 gm. of 48% alcohol). This is the German Ehrenfeld program, discovered by Udo Ehrenfeld, Max Planck Institute for Coal Res., around 1974. Main indications are melanomas (protective therapy) and primary brain tumors. With a positive response rate of 80%, a requirement in modern oncology.

2) Benzaldehyde (the Japanese Kochi). In tocopherol (vitamin E) for a better stabilization. (Cancer Therapy Reports, Natl. Cancer Inst. USA, Jan. 1980). For all forms of malignancies.

    Kochi had originally stabilized the benzaldehyde in beta-cyclodextrin. The clinical results which he reported in 1980 were substantially better than those we could obtain with a benzaldehyde stabilized in tocopherol (vitamin E) as an antioxidant. We have, therefore, adopted the original Kochi preparation for the further and far more efficacious treatment of cancer. The legal regulations in Germany permit the individual prescription of cyclodextrine benzaldehyde. This preparation is like all the other benzaldehyde donors free from any noteworthy side effects.

3) Amygdalin, prunasin, ficin etc., benzaldehyde donors found in the flora. All kinds of malignancies.

4) Laetrile, the l-glucose variation of amygdalin. Due to its tumor specificity, very effective. Unfortunately no longer existing since the early 50s. No attempt has been made to regrow apricots manufacturing laetrile, by genetic manipulations.

5) Ureyl-Mandelonitrile (replacing glucose by urea). Developed by Kohler and Nieper, 1977. All malignancies, especially chronic leukemias. Individual potions prescribable in Germany. Also Nicotinyl-mandelonitrile, Paraamino-benzyl-mandelonitrile.

    Ureyl-Mandelonitrile has become a mainstay with us for almost 20 years in the protective longtime treatment of prostate malignancies, including their metastasization.

6) Didrovaltrate, found in the Himalayan valerian plant. The substance has to be converted into an activated di-aldehyde, by e.g. pancreas esterases or by electromagnetic effects in e.g. cell membranes. A varnish-like substance, specific antimalignant property found by Anton, Univ. of Strassburg, France, 1981. Today, a preferable treatment for urogenital and kidney tumors. Difficult to take. At least 20 - 22 pills per day, 1 gram each. At best with warm non-alcohol beer. Several years of application required as in all these substances.

7) Iridodial, found in ants. An activable di-aldehyde, potentially an extremely powerful genetic repair factor. Antimalignant properties first defined by Thies, Solvay Kali Chemie, Hannover, Germany (1985). First observations of pulmonary tumor regressions by Didier, Gifhorn, Germany 1952. Extraction of natural iridomyrmex ants gives very small yields and can hardly be amplified. The German Society of Oncology, by its lay organization Biological Cancer Defense has, therefore, started a research program to obtain iridodial in larger quantities, synthetically and semi-synthetically. Also iridodial-like compounds are found in other, e.g. European ants. Also these most important anti-malignant properties have been observed in realistic clinical cases.

    The iridodial research is in my opinion the spearhead realistic, cancer therapy research at the end of this century.

Kochi, Matsuyuki, et al. Antitumor Activity of Benzaldehyde. Cancer Therapy Reports, Natl. Inst. of Health Vol. 64, 1, p. 21-23 (1980)

Thies, Peter W. Iridoide und andere terpenoide Naturstoffe (Antineoplastica) Pharmazie in unserer Zeit, Vol. 14, 2, p. 33-38 (1985). 

Nieper, H.A., and Kohler, F. Ureylmandelonitrile Document. The A. Keith Brewer Sc. Library, Richland Center, Wisconsin 53581 USA.

Bouthan, C., Anton, R. et al. Valepotriates: A new class of cytotoxic and antitumor agents. Planta Medica 41, 21-28 (1981).

 

Dr. Hans A. Nieper
Director, Dept. of Medicine
The Paracelsus Silbersee Hospital
Hannover, Germany

 


http://www.tldp.com
info@townsendletter.com
360-385-6021
360-385-0699 (
fax)

1983-2002 Townsend Letter for Doctors and Patients
All Rights Reserved.

ADVERTISERS CLICK HERE FOR INFO